Clinical Trials Targeting Secondary Damage after Traumatic Spinal Cord Injury

Area of Science:

• Neuroscience
• Regenerative Medicine
• Clinical Trials

Background:

• Spinal cord injury (SCI) leads to significant sensory and motor function loss.
• Existing treatments do not repair spinal cord tissue.
• Secondary injury, an inflammatory response, exacerbates primary SCI damage.

Purpose of the Study:

• To review clinical trials of neuroprotective therapeutics for SCI.
• To focus on therapies mitigating secondary injury.
• To explore strategies from the last decade.

Main Methods:

• Categorization of neuroprotective strategies: acute-phase interventions, systemic pharmacological agents, and cell-based therapies.
• Review of clinical trials within the last decade.
• Summary of combinatorial therapy potential.

Main Results:

• Neuroprotective strategies aim to mitigate secondary injury progression.
• Clinical trials investigate diverse approaches including surgical, pharmacological, and cellular interventions.
• Combinatorial therapies show potential for enhanced outcomes.

Conclusions:

• Targeting secondary injury is a critical strategy for improving SCI patient outcomes.
• A range of neuroprotective therapies are under clinical investigation.
• Future research should consider combined therapeutic approaches for SCI treatment.